๐ฌDeep Research
ABBV โ AbbVie ยท catalysts, narrative & risks
Quick Snapshot (as of 2026-10-03)
AbbVie (NYSE:ABBV) is a Chicago-based biopharmaceutical company. In early October 2026 the stock trades in the low-$260s โ Yahoo Finance shows a previous close of $259.93 with a day range of $257.87โ$264.06, and another quote places it near $263.61, up ~18% year-to-date โ with a market cap of roughly $464B and a 52-week range of $190.75โ$269.39 [20]. A 1-year analyst price target sits around $278.86 [20]. The company pays a forward dividend on the order of $6.83โ$6.92 per share (about a 2.66% yield) [2][20].
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ